AEterna Zentaris
(NASDAQ:AEZS)
Aeterna Zentaris Inc. - Common Stock recently split on Thursday, July 21, 2022 with a ratio of 1:25
$4.97
Last update: 3:28PM
Day High/Low4.81 - 5.03
52 Week High/Low0.16 - 5.9
Open / Close4.85 / -
Float / Outstanding4.9M / 4.9M
Vol / Avg.60.1K / 1.2M
Mkt Cap24.1M
P/E-
50d Avg. Price1.28
Div / Yield-
Payout Ratio-
EPS-0.87
Total Float4.9M

AEterna Zentaris (NASDAQ:AEZS), Quotes and News Summary

AEterna Zentaris (NASDAQ: AEZS)

Day High/Low4.81 - 5.03
52 Week High/Low0.16 - 5.9
Open / Close4.85 / -
Float / Outstanding4.9M / 4.9M
Vol / Avg.60.1K / 1.2M
Mkt Cap24.1M
P/E-
50d Avg. Price1.28
Div / Yield-
Payout Ratio-
EPS-0.87
Total Float4.9M
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-03
REV
Q2 2022Est.ActualSurprise
EPS-0.680-0.870 -0.1900
REV1.310M-222.000K-1.532M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

AEterna Zentaris Questions & Answers

Q
How do I buy AEterna Zentaris (AEZS) stock?
A

You can purchase shares of AEterna Zentaris (NASDAQ: AEZS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are AEterna Zentaris's (AEZS) competitors?
A

There are no as such competitors for AEterna Zentaris.

Q
What is the target price for AEterna Zentaris (AEZS) stock?
A

The latest price target for AEterna Zentaris (NASDAQ: AEZS) was reported by HC Wainwright & Co. on Wednesday, March 30, 2022. The analyst firm set a price target for 1.50 expecting AEZS to fall to within 12 months (a possible -69.82% downside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for AEterna Zentaris (AEZS)?
A

The stock price for AEterna Zentaris (NASDAQ: AEZS) is $4.97 last updated Today at August 8, 2022, 7:28 PM UTC.

Q
Does AEterna Zentaris (AEZS) pay a dividend?
A

There are no upcoming dividends for AEterna Zentaris.

Q
When is AEterna Zentaris (NASDAQ:AEZS) reporting earnings?
A

AEterna Zentaris’s Q3 earnings are confirmed for Thursday, November 3, 2022.

Q
Is AEterna Zentaris (AEZS) going to split?
A

There is no upcoming split for AEterna Zentaris.

Q
What sector and industry does AEterna Zentaris (AEZS) operate in?
A

AEterna Zentaris is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.